ALVEOLITIS FIBROSING side effect
What is ALVEOLITIS FIBROSING ?Drugs associated with ALVEOLITIS FIBROSING
ACTOS ALEMTUZUMAB ATORVASTATIN ENBREL FLUDARABINE HUMIRA INFLIXIMABALVEOLITIS FIBROSING : Alemtuzumab Side Effects Report #5584090-9
Health Professional from UNITED KINGDOM reported ALEMTUZUMAB problem on Nov 26, 2007. Male patient, 25 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression, lymphoproliferative disorder and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, anaemia, ascites, cryptogenic organising pneumonia, febrile neutropenia, gastrointestinal haemorrhage, hepatic cirrhosis, melaena, . ALEMTUZUMAB dosage: unknown. During the same period patient was treated with FLUDARABINE, MELPHALAN, CYCLOSPORINE, RITUXIMAB. Patient died.
ALVEOLITIS FIBROSING : Alemtuzumab Side Effects Report #5545993-4
ALEMTUZUMAB problem was reported by a Health Professional from UNITED KINGDOM on Nov 26, 2007. Male patient, 25 years of age, was diagnosed with bone marrow conditioning regimen, immunosuppression, lymphoproliferative disorder and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, anaemia, ascites, cryptogenic organising pneumonia, febrile neutropenia, gastrointestinal haemorrhage, hepatic cirrhosis, melaena, . ALEMTUZUMAB dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, CYCLOSPORINE, RITUXIMAB. Patient died.
ALVEOLITIS FIBROSING : Enbrel Side Effects Report #5525594-4
Health Professional from UNITED KINGDOM reported ENBREL problem on Nov 13, 2007. Female patient, weighting 205.0 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.
ALVEOLITIS FIBROSING : Fludarabine Side Effects Report #5528424-X
FLUDARABINE PHOSPHATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 07, 2007. Male patient, 25 years of age, was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, anaemia, ascites, cryptogenic organising pneumonia, erosive duodenitis, febrile neutropenia, gastrointestinal haemorrhage, gastrointestinal oedema, haemodialysis, . FLUDARABINE PHOSPHATE dosage: (30 MG/M2). During the same period patient was treated with ALEMTUZUMAB, MELPHALAN. Patient died.
ALVEOLITIS FIBROSING : Actos Side Effects Report #5493520-2
Consumer or non-health professional from UNITED KINGDOM reported ACTOS problem on Oct 04, 2007. Male patient, 79 years of age, was diagnosed with diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, . ACTOS dosage: 30 MG. During the same period patient was treated with ASPIRIN, GLICLAZIDE, LISINOPRIL, OMEPRAZOLE, PRAVASTATIN. Patient recovered.
ALVEOLITIS FIBROSING : Enbrel Side Effects Report #5496136-7
ENBREL problem was reported by a Health Professional from UNITED KINGDOM on Oct 15, 2007. Female patient, 61 years of age, was diagnosed with psoriatic arthropathy, polymyalgia rheumatica and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE, AMITRIPTYLINE, CALCICHEW, PANTOPRAZOLE, DICLOFENAC, FOLIC ACID. Patient recovered.
ALVEOLITIS FIBROSING : Atorvastatin Side Effects Report #5418603-4
Consumer or non-health professional from AUSTRALIA reported ATORVASTATIN CALCIUM problem on Aug 07, 2007. Male patient, weighting 160.9 lb, was diagnosed with coronary artery disease and was treated with ATORVASTATIN CALCIUM. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, bacterial infection, chronic obstructive pulmonary disease, hypokalaemia, lymphadenopathy mediastinal, pneumonia, pulmonary hypertension, respiratory tract infection, right atrial dilatation, . ATORVASTATIN CALCIUM dosage: DAILY DOSE:20MG. During the same period patient was treated with PERINDOPRIL ERBUMINE, ASPIRIN, GLICLAZIDE, METFORMIN, AMOXICILLIN, PENICILLIN G, DOXYCYCLINE. Patient was hospitalized. Patient recovered.
ALVEOLITIS FIBROSING : Infliximab Side Effects Report #5436495-4
INFLIXIMAB problem was reported by a Health Professional from UNITED KINGDOM on Aug 22, 2007. Male patient, 67 years of age, was diagnosed with rheumatoid arthritis and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, . INFLIXIMAB dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PREDNISOLONE. Patient died.
ALVEOLITIS FIBROSING : Atorvastatin Side Effects Report #5386797-5
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on July 04, 2007. Male patient, 63 years of age, weighting 205.0 lb, was diagnosed with blood cholesterol increased, dyspepsia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, . ATORVASTATIN dosage: unknown. During the same period patient was treated with LANSOPRAZOLE. Patient recovered.
ALVEOLITIS FIBROSING : Humira Side Effects Report #5397180-0
HUMIRA problem was reported by a Health Professional from UNITED KINGDOM on July 16, 2007. Male patient, weighting 149.9 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, lower respiratory tract infection, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, ARCOXIA, FERROUS SULPHATE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
ALVEOLITIS FIBROSING : Atorvastatin Side Effects Report #5386797-5
Health Professional from UNITED KINGDOM reported ATORVASTATIN problem on July 04, 2007. Male patient, 63 years of age, weighting 205.0 lb, was diagnosed with blood cholesterol increased, dyspepsia and was treated with ATORVASTATIN. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, . ATORVASTATIN dosage: unknown. During the same period patient was treated with LANSOPRAZOLE. Patient recovered.
ALVEOLITIS FIBROSING : Humira Side Effects Report #5397180-0
HUMIRA problem was reported by a Health Professional from UNITED KINGDOM on July 16, 2007. Male patient, weighting 149.9 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: alveolitis fibrosing, lower respiratory tract infection, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, ARCOXIA, FERROUS SULPHATE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
ALVEOLITIS FIBROSING : Infliximab Side Effects Report #5383863-5
Health Professional from UNITED KINGDOM reported INFLIXIMAB problem on June 29, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, alveolitis fibrosing, lung infection, malaise, pyrexia, urinary tract infection, . INFLIXIMAB dosage: unknown. During the same period patient was treated with LEFLUNOMIDE, ROFECOXIB, ESOMEPRAZOLE MAGNESIUM, ALENDRONATE, CALCIUM CHLORIDE. Patient was hospitalized. Patient died on 06/13/2002.
ALVEOLITIS FIBROSING : Infliximab Side Effects Report #5383863-5
INFLIXIMAB problem was reported by a Health Professional from UNITED KINGDOM on June 29, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, alveolitis fibrosing, lung infection, malaise, pyrexia, urinary tract infection, . INFLIXIMAB dosage: unknown. During the same period patient was treated with LEFLUNOMIDE, ROFECOXIB, ESOMEPRAZOLE MAGNESIUM, ALENDRONATE, CALCIUM CHLORIDE. Patient was hospitalized. Patient died on 06/13/2002.